San Francisco AIDS Foundation

Approved Antiretroviral Drugs

Winter 2005/2006

This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

Generic (Common) Name	Brand Name	Company	Year Approved
Protease Inhibitors (PIs)
amprenavir	Agenerase	GlaxoSmithKline	1999; discontinued 2004
atazanavir	Reyataz	Bristol-Myers Squibb	2003
fosamprenavir	Lexiva (U.S.); Telzir (Europe)	GlaxoSmithKline	2003
indinavir	Crixivan	Merck	1996
lopinavir/ritonavir	Kaletra	Abbott	2000; Meltrex formulation 2005
nelfinavir	Viracept	Pfizer	1997
ritonavir	Norvir	Abbott	1996
saquinavir	Invirase (hard-gel) Fortovase (soft-gel)	Roche	1995 1997; withdrawn 2005
tipranavir	Aptivus	Boehringer Ingelheim	2005
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
abacavir	Ziagen	GlaxoSmithKline	1998
didanosine (ddI)	Videx	Bristol-Myers Squibb	1989; extended release Videx EC 2000
emtricitabine (FTC)	Emtriva	Gilead	2003
lamivudine (3TC)	Epivir	GlaxoSmithKline	1995
stavudine (d4T)	Zerit	Bristol-Myers Squibb	1994
zalcitabine (ddC)	Hivid	Roche	1992; withdrawn 2005
zidovudine (AZT)	Retrovir	GlaxoSmithKline	1987
tenofovir DF	Viread	Gilead	2002
NRTI Fixed-Dose Combinations
zidovudine/lamivudine	Combivir	GlaxoSmithKline	1997
zidovudine/lamivudine/abacavir	Trizivir	GlaxoSmithKline	2000
lamivudine/abacavir	Epzicom (U.S.); Kivexa (Europe)	GlaxoSmithKline	2004
tenofovir/emtricitabine	Truvada	Gilead	2004
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
delavirdine	Rescriptor	Pfizer	1997
efavirenz	Sustiva (U.S.); Stocrin (elsewhere)	Bristol-Myers Squibb	1998
nevirapine	Viramune	Boehringer Ingelheim	1996
Entry/Fusion Inhibitors
enfuvirtide (T-20)	Fuzeon	Trimeris	2003

Back to the SFAF BETA Winter 2005/2006 contents page.

This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS.

More on the First Steps to HIV Treatment

HIV Medications: When to Start and What to Take -- A Guide From TheBody.com

More on the First Steps to HIV Treatment

HIV Medications: When to Start and What to Take -- A Guide From TheBody.com

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

World AIDS Day 2009: Home

HIV Antiretrovirals in Development: An Update From ICAAC 2009

Back From the Brink: A Blog Entry by Thomas DeLorenzo

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.